Recombinant ADAMTS13 Effective, Safe in Congenital Thrombotic Thrombocytopenic Purpura
Treatment had few adverse events and increased ADAMTS13 activity versus standard therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.